Pioneering transformational drug discovery and development in the areas of cancer and fibrosis
RXC004 – Clinical Phase 1 study ongoing
Pioneering transformational drug discovery and development in the areas of cancer and fibrosis
Lead fibrosis programme – Pan-ROCK inhibitor for fibrosis related to IBD
GBX 7.80GBp
LON : REDX 21/08/2018 11:57AM

Drug discovery and development business creating high value cancer and fibrosis therapeutics

More about Redx Pharma